To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
Commentary|Videos|June 19, 2026
A Roadmap to Dispenser DSCSA Readiness
Justin Macy, PharmD, JD, and Andrew Funk, PharmD, of NABP, emphasize that compliance is a critical safeguard against the rising threat of counterfeit and illegitimate products.
Advertisement
Advertisement
As the final implementation milestone for the Drug Supply Chain Security Act (DSCSA) approaches this November, small dispensers—those with fewer than 25 full-time employees—must finalize their transition into a fully interoperable digital supply chain.
Related to this article
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
A newly erected Women’s Health Division within NIH will work in tandem with the Office of Research on Women’s Health.
Rita King, CEO of MethodSense, provides her expertise on the integration of AI in medical devices and key developments for pharmacists as the technology evolves.
Harini Bupathi, Esq, explains why pharmacies need to continue prioritizing PBM relationships despite rapid legislative change.
Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.
AJ Barbarito, Esq, explains how ERISA and Medicare Part D preemption limit state PBM laws and why a private right of action may be the most effective path forward.
Advertisement
Advertisement